Cargando…
PReS-FINAL-2143: Treat-to-target strategy in juvenile idiopathic arthritis: experience in 175 newly-diagnosed patients
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4043642/ http://dx.doi.org/10.1186/1546-0096-11-S2-P155 |
_version_ | 1782318953449652224 |
---|---|
author | Negro, G Consolaro, A Verazza, S Bracciolini, G Rosina, S Pignataro, R Civino, A Martini, A Ravelli, A |
author_facet | Negro, G Consolaro, A Verazza, S Bracciolini, G Rosina, S Pignataro, R Civino, A Martini, A Ravelli, A |
author_sort | Negro, G |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4043642 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-40436422014-06-17 PReS-FINAL-2143: Treat-to-target strategy in juvenile idiopathic arthritis: experience in 175 newly-diagnosed patients Negro, G Consolaro, A Verazza, S Bracciolini, G Rosina, S Pignataro, R Civino, A Martini, A Ravelli, A Pediatr Rheumatol Online J Poster Presentation BioMed Central 2013-12-05 /pmc/articles/PMC4043642/ http://dx.doi.org/10.1186/1546-0096-11-S2-P155 Text en Copyright © 2013 Negro et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Poster Presentation Negro, G Consolaro, A Verazza, S Bracciolini, G Rosina, S Pignataro, R Civino, A Martini, A Ravelli, A PReS-FINAL-2143: Treat-to-target strategy in juvenile idiopathic arthritis: experience in 175 newly-diagnosed patients |
title | PReS-FINAL-2143: Treat-to-target strategy in juvenile idiopathic arthritis: experience in 175 newly-diagnosed patients |
title_full | PReS-FINAL-2143: Treat-to-target strategy in juvenile idiopathic arthritis: experience in 175 newly-diagnosed patients |
title_fullStr | PReS-FINAL-2143: Treat-to-target strategy in juvenile idiopathic arthritis: experience in 175 newly-diagnosed patients |
title_full_unstemmed | PReS-FINAL-2143: Treat-to-target strategy in juvenile idiopathic arthritis: experience in 175 newly-diagnosed patients |
title_short | PReS-FINAL-2143: Treat-to-target strategy in juvenile idiopathic arthritis: experience in 175 newly-diagnosed patients |
title_sort | pres-final-2143: treat-to-target strategy in juvenile idiopathic arthritis: experience in 175 newly-diagnosed patients |
topic | Poster Presentation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4043642/ http://dx.doi.org/10.1186/1546-0096-11-S2-P155 |
work_keys_str_mv | AT negrog presfinal2143treattotargetstrategyinjuvenileidiopathicarthritisexperiencein175newlydiagnosedpatients AT consolaroa presfinal2143treattotargetstrategyinjuvenileidiopathicarthritisexperiencein175newlydiagnosedpatients AT verazzas presfinal2143treattotargetstrategyinjuvenileidiopathicarthritisexperiencein175newlydiagnosedpatients AT bracciolinig presfinal2143treattotargetstrategyinjuvenileidiopathicarthritisexperiencein175newlydiagnosedpatients AT rosinas presfinal2143treattotargetstrategyinjuvenileidiopathicarthritisexperiencein175newlydiagnosedpatients AT pignataror presfinal2143treattotargetstrategyinjuvenileidiopathicarthritisexperiencein175newlydiagnosedpatients AT civinoa presfinal2143treattotargetstrategyinjuvenileidiopathicarthritisexperiencein175newlydiagnosedpatients AT martinia presfinal2143treattotargetstrategyinjuvenileidiopathicarthritisexperiencein175newlydiagnosedpatients AT ravellia presfinal2143treattotargetstrategyinjuvenileidiopathicarthritisexperiencein175newlydiagnosedpatients |